ArticleDiagnostics (Basel, Switzerland)2022

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma.

Zhimin Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.